Skip to main content

Impax Asset Management Group plc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1749768 LONDON, X0

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$9,880,500
-$756,750 QoQ
Shares Held
75,000
0.0% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Impax Asset Management Group plc holds $185,664,890 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
75,000 $9,880,500

All Filings in NBIX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,880,500 75,000
2025-12-31 $10,637,250 75,000
2025-09-30 $10,528,500 75,000
2025-06-30 $14,454,350 115,000
2025-03-31 $11,060,000 100,000
2024-12-31 $35,708,263 261,599
2024-09-30 $9,793,700 85,000
2024-06-30 $6,883,500 50,000
2024-03-31 $6,896,000 50,000
2023-12-31 $14,493,600 110,000
2023-09-30 $15,187,500 135,000
2023-06-30 $18,860,000 200,000
2023-03-31 $20,244,000 200,000
2022-12-31 $20,902,000 175,000
2022-09-30 $15,931,500 150,000
2020-03-31 $6,491,250 75,000